Abstract
Objective: To determine the risk of the locomotive syndrome with knee osteoarthritis grades and different factors.
Methodology: This pilot study was conducted in Benazir Bhutto Hospital, Rawalpindi from March to June 2018 and included 30 patients through Non-probability sampling technique. Inclusion criteria were both gender of age 45-65 years having grade II, III knee osteoarthritis and knee pain on most days of the past month with average pain severity of >4 on an 11 point numerical rating scale. Risk of the locomotive syndrome in these patients was assessed through 25- Risk Questionnaire, Two-Step Test and Stand up Test. Data were analyzed on SPSS version 21.
Results: Mean age was 49.5±3.44 years. Odds ratios showed that locomotive risk increased with Grade III osteoarthritis as compared to Grade II with odds ratios test of 25 Risk questionnaires 5.6, two-step test 9.3 and Stand up test 8.3. P-value for gender and socioeconomic status was less than 0.05.
Conclusion: Risk of Locomotive Syndrome is high with grade III knee osteoarthritis as compare to grade II.

Key words: Knee osteoarthritis, locomotive syndrome, stand-up test.

Similar Articles

Promising influences of Scutellaria baicalensis and its two active constituents, baicalin, and baicalein, against metabolic syndrome: A review.
Baradaran Rahimi V, Askari VR, Hosseinzadeh H
Phytotherapy research : PTR. 2021; ():

Comparing the Effects of Massage Therapy and Aromatherapy on Knee Pain, Morning Stiffness, Daily Life Function, and Quality of Life in Patients with Knee Osteoarthritis.
Hasanpour-Dehkordi A, Kabiri F, Dris F
Complementary medicine research. 2021; (): 1-8

Could the use of saliva substitutes improve food oral processing in individuals with xerostomia? A systematic review.
Piaton S, Duconseille A, Roger-Leroi V, Hennequin M
Journal of texture studies. 2021; ():

A meta-meta-analysis: Evaluation of meta-analyses published in the effectiveness of cardiovascular comorbidities on the severity of COVID-19.
Naeini MB, Sahebi M, Nikbakht F, Jamshidi Z, Ahmadimanesh M, Hashemi M, Ramezani J, Miri HH, Yazdian-Robati R
Obesity medicine. 2021; 22(): 100323

A quantitative test of the face validity of behavior-change messages based on the Brazilian Dietary Guidelines.
Khandpur N, Quinta FP, Jaime PC
Nutrition journal. 2021; 20(1): 10

Severe toxicity of capecitabine in a patient with DPD deficiency after a safe FEC-100 experience: why we should test DPD deficiency in all patients before high-dose fluoropyrimidines.
Maillard M, Eche-Gass A, Ung M, Brice A, Marsili S, Montastruc M, Puisset F, Thomas F
Cancer chemotherapy and pharmacology. 2021; ():

Induction of aryl hydrocarbon receptor in granulosa cells by endoplasmic reticulum stress contributes to pathology of polycystic ovary syndrome.
Kunitomi C, Harada M, Kusamoto A, Azhary JMK, Nose E, Koike H, Xu Z, Urata Y, Takahashi N, Wada-Hiraike O, Hirota Y, Koga K, Fujii T, Osuga Y
Molecular human reproduction. 2021; ():

Genetic modifiers in rare disorders: the case of fragile X syndrome.
Crawford H, Scerif G, Wilde L, Beggs A, Stockton J, Sandhu P, Shelley L, Oliver C, McCleery J
European journal of human genetics : EJHG. 2021; 29(1): 173-183